Skip to main content
. 2014 Oct 3;9(10):e108477. doi: 10.1371/journal.pone.0108477

Figure 6. Paricalcitol induced the regulation of IL-17 production and affected peritoneal fibrosis outcomes.

Figure 6

A) Peritoneal concentrations of IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IFN-γ and TNF-α were not affected by paricalcitol treatment. B) Paricalcitol induced the suppression of IL-17 production in the peritoneal membrane. C) The IL-17 concentrations strongly correlate with peritoneal fibrosis. n≥5 in each group. Statistical significance was determined using the Mann-Whitney test. **P<.01. A correlation analysis was performed using Spearman's nonparametric test.